Since the association of excessive deposits of iron with cirrhosis of the liver and fibrosis of the pancreas was first described in haemochromatosis, it has been postulated that excessive accumulation ofiron may be harmful to the tissues. The term 'siderosis' was coined by Neumann in 1888, and originally it was applied to conditions in which stainable iron was found in the tissues, especially to conditions in which there was haemolysis. Sheldon (1935) emphasized the difference between haemosiderosis and haemochromatosis: haemosiderosis represented the deposition of iron pigment which was due to the destruction of red blood cells, and this was produced either experimentally or it resulted from a disease process. Finch and Finch (1955) defined haemochromatosis as iron deposition that caused cirrhosis and other tissue damage while in haemosiderosis the iron had not caused tissue damage. The pathological criteria used for the diagnosis of haemochromatosis were those proposed by MacDonald and Mallory (1960) . They were as follows: (1) cirrhosis of the liver of a 'portal' type, with (2) excessive iron deposits in hepatic parenchymal cells, in connective tissue, and in bile duct epithelium; (3) pancreatic fibrosis and haemosiderosis; and (4) parenchymal iron deposits in other organs of the body.
The possibility that cirrhosis was due to iron pigment was first suggested by Hanot and Chauffard Received for publication 31 December 1968 in 1882. They believed that iron and blood pigment acted as irritating substances which led to fibrosis. Sheldon (1935) also believed that iron set up an irritation which was followed by degeneration or atrophy of cells, the atrophied cells being replaced by fibrosis. But he considered that excessive destruction of blood and subsequent storage of iron would not cause haemochromatosis, but only a simple haemosiderosis without tissue damage. Thus, one theory is that cirrhosis is the result of the presence of iron pigment. Muir (1922) stated that cirrhosis of the liver and fibrosis of the pancreas occurred first, and this was followed by increased deposition of iron in the parenchymal cells of the organs and other damaged areas. A third theory is that cirrhosis and iron deposition are independent processes. In 1933, Polson after extensive studies in experimental animals in which he failed to produce tissue damage with iron, concluded that cirrhosis and iron pigmentation were independent.
This problem is investigated in the present study by assessment at necropsy of the effects of large quantities of iron retained in the liver and other tissues. These were cases of anaemias where life was sustained over long periods by multiple blood transfusions. MATERIALS (Sinniah, 1967 Liver function tests were normal. A fractional test meal revealed marked hyperchlorhydria. An x-ray barium meal examination suggested the presence of a small acute ulcer in the duodenum. As a consequence, the anaemia was attributed to gastrointestinal haemorrhage and treatment was directed towards correcting the anaemia by giving transfusions of concentrated red cells. During the next four months, despite continuous iron therapy, it proved impossible to maintain the haemoglobin level, and repeated transfusions were necessary. In this period the patient received 23 pints of blood. Treatment with iron and ascorbic acid was recommenced, and the serum iron was found to be 470 ,ug/100 ml and a total iron-binding capacity (TIBC) of 482 jug/100 ml.
By this time his skin had acquired a slate-grey pigmentation, the liver had enlarged to 3 in. (7 5 cm) below the costal margin, and the spleen had become palpable. His clinical condition had greatly deteriorated and was complicated by a return of congestive cardiac failure.
The patient had received at least the following amount of iron: 23 pints of blood = 5 75 g (500 ml of blood contains approximately 250 mg of iron), 130 ml of Imferon = 7 50 g, and 39 g of oral iron = 3 90 g, on the assumption that he absorbed 10% of the oral dose (Chodos, Ross, Apt, Pollycove, and Halkett, 1957; PirzioBiroli, Bothwell, and Finch, 1958; Peterson, 1960) . Thus the patient had received at least 17-20 g of iron. In addition to blood transfusions, 150 mg of pyridoxine was given daily, with dramatic clinical improvement.
In 1961 a liver biopsy was performed, and it showed cirrhosis with marked haemosiderosis.
In 1964 there was still a good response to pyridoxine and the haemoglobin was satisfactory, but hepatomegaly and skin pigmentation were marked. The patient was given a short course of desferrioxamine-B to chelate iron from the liver as it was thought that the cirrhosis was due to the irritative action of haemosiderin. The patient became increasingly dyspnoeic and had some wheezy bronchitis with a lot of mucoid sputum, and he developed intermittent signs of right heart failure. Liver function tests were slightly abnormal and the serum iron level was 191 Htg/l00 ml. The liver was enlarged and extended to the umbilicus.
The patient died at home in 1966. Necropsy findings (abnormal findings only) There was a generalized greyish-brown pigmentation of the skin, especially marked on the face, arms, and hands.
The liver was enlarged and weighed 2,000 g. The surface was finely nodular, and on section the parenchyma had a rusty brown coloration, and there was a fine cirrhosis. On microscopic examination the lobular pattern was disrupted by coarse fibrous septa (Fig. 2) which subdivided the parenchyma into nodules of regenerating liver cells. The fibrous septa enclosed two or more lobules in some areas. Within the fibrous septa there was bile duct proliferation and a mild degree of haemosiderin deposition. In other areas, the fibrous septa were fine and surrounded single lobules. The pancreas was a deep brown colour indicative of a heavy deposition of iron. The peripancreatic lymph nodes were also brown. On histological examination (Fig. 3) the architecture was seen to be disturbed due to a marked increase in interstitial fibrous tissue which ran between atrophic acini. Haemosiderin could be seen within the acinar cells and cells of the islets of Langerhans.
The spleen was moderately enlarged and weighed 400 g. The pulp was congested and contained an excessive amount of haemosiderin.
Iron pigment was present in the cells of the zona glomerulosa of the adrenal glands.
Haemosiderin was deposited in an occasional tubule of the kidneys.
There was no deposition of haemosiderin in the myocardial fibres and no evidence of a myopathy was seen.
There was no excess melanin in the epidermis, and no iron was present in the skin appendages, dermis, and epidermis.
DISCUSSION
Hepatic cirrhosis with haemosiderosis was diagnosed by a liver biopsy three years after the commencement of blood transfusions and both oral and parenteral iron therapy. The patient had received at least 17-2 g of iron into the tissues. Liver cirrhosis and pancreatic fibrosis were confirmed at necropsy five years later. The crux of the problem is to consider if hepatic cirrhosis and pancreatic fibrosis were caused by the haemosiderin acting as an irritant and inducing cellular damage or whether the two conditions were separate.
The first case of haemochromatosis associated with multiple blood transfusions was reported by Kark in 1937 Schwartz and Blumenthal (1948) reported five patients who died as a result of a variety of diseases, all characterized by severe anaemia for which numerous transfusions had been given, and all of whom developed features of haemochromatosis. They postulated that the haemochromatosis developing in these patients is the end result of the deposition and subsequent irritating action of iron in the cells. Cappell, Hutchison, and Jowett (1957) In the present study of six cases with transfusional siderosis, hepatic cirrhosis was found in only one patient (case 4). During a three-year period the patient received at least 17-2 g of iron in the form of blood transfusions, oral and parenteral iron. Liver biopsy at the end of three years showed definite cirrhosis with severe haemosiderosis. Both hepatic cirrhosis and pancreatic fibrosis with haemosiderosis were confirmed at necropsy. Cases 1, 5, and 6 (see Table) had received at least 38 g, 29 g, and 24 g of iron in blood transfusions and survived for periods of four, 10, and five years without the development of cirrhosis. Thus, if duration and intensity of iron therapy were the only factors concerned, the fibrosis should be most marked in those patients who had received the greatest amount of blood over the longest period, and this is not so.
Cappell et al (1957) (Cappell, 1930; Polson, 1933; Finch et al, 1950; Sinniah, 1967) . In man with iron overload resulting from the treatment of non-regenerative anaemia by transfusion, there is a similar failure to demonstrate unequivocally a fibrogenic action of the transfused iron. According to Cappell et al (1957) it seems probable that at least some forms of iron are virtually non-fibrogenic. It may be possible that iron absorbed from the gut and stored in excess without having passed through the haemoglobin molecule may not be bland. The cases recorded by Robbins (1958) and Turnberg (1965) , in which siderosis and hepatic cirrhosis were attributed to prolonged oral intake of iron for anaemia, may be cases in point, but these cases are still too few to arrive at a definite conclusion. Thus, the behaviour in the body of excess iron derived from various sources may be different. Iron derived from the gut may be toxic and irritant when stored for long periods in excess, whereas iron derived from effete red cells may be relatively bland, having passed through the haemoglobin molecule (Cappell et al, 1957) . Perhaps iron derived from the breakdown of red blood cells may not be irritant owing to its passage through the reticuloendothelial system. It may be possible that iron derived from any source is not toxic, and the cirrhosis in haemochromatosis is due to some other factor, possibly a specific but as yet unidentified hepatic enzyme comparable to what occurs in galactosaemia, in which the liver and red blood cells have been shown to lack the specific enzyme galactose-l-phosphateurkdy1 transferase which is essential for galactose metabolism (Kalckar, Anderson, and Isselbacher, 1956) and in which hepatic cirrhosis is found.
